"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Descriptor ID |
D009369
|
MeSH Number(s) |
C04
|
Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 8 | 7 | 15 |
1995 | 17 | 3 | 20 |
1996 | 14 | 6 | 20 |
1997 | 15 | 9 | 24 |
1998 | 14 | 3 | 17 |
1999 | 12 | 2 | 14 |
2000 | 17 | 5 | 22 |
2001 | 21 | 5 | 26 |
2002 | 26 | 9 | 35 |
2003 | 35 | 10 | 45 |
2004 | 47 | 13 | 60 |
2005 | 34 | 12 | 46 |
2006 | 36 | 12 | 48 |
2007 | 52 | 14 | 66 |
2008 | 49 | 12 | 61 |
2009 | 46 | 10 | 56 |
2010 | 51 | 6 | 57 |
2011 | 60 | 14 | 74 |
2012 | 70 | 10 | 80 |
2013 | 65 | 14 | 79 |
2014 | 91 | 16 | 107 |
2015 | 109 | 10 | 119 |
2016 | 77 | 22 | 99 |
2017 | 92 | 11 | 103 |
2018 | 91 | 9 | 100 |
2019 | 109 | 17 | 126 |
2020 | 113 | 10 | 123 |
2021 | 130 | 6 | 136 |
2022 | 108 | 1 | 109 |
2023 | 103 | 1 | 104 |
2024 | 16 | 0 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Interventions addressing health-related social needs among patients with cancer. J Natl Cancer Inst. 2024 Apr 05; 116(4):497-505.
-
Outcomes of parenteral nutrition in patients with advanced cancer and malignant bowel obstruction. Support Care Cancer. 2024 Mar 04; 32(3):206.
-
Concordance in Molecular Tumor Board Case Reviews in the ASCO TAPUR Study. JCO Precis Oncol. 2024 Mar; 8:e2300615.
-
The ENGAGE study: a 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative PCP model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivors. BMC Health Serv Res. 2024 Feb 28; 24(1):253.
-
Pan-cancer proteogenomics characterization of tumor immunity. Cell. 2024 Feb 29; 187(5):1255-1277.e27.
-
Efficient Synthesis and HPLC-Based Characterization for Developing Vanadium-48-Labeled Vanadyl Acetylacetonate as a Novel Cancer Radiotracer for PET Imaging. Molecules. 2024 Feb 09; 29(4).
-
Special designations and the US Food and Drug Administration's "dual mandate". J Natl Cancer Inst. 2024 Feb 08; 116(2):177-179.
-
Nontumor Cells in Tumor Samples Bias Expression-Based Models-Reply. JAMA Oncol. 2024 Feb 01; 10(2):260-261.
-
Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders. Best Pract Res Clin Haematol. 2024 Mar; 37(1):101537.
-
NF-?B: Governing Macrophages in Cancer. Genes (Basel). 2024 Jan 31; 15(2).